Camlin Fine Sciences Acquires Majority Stake in Vinpai
November 27, 2025
Camlin Fine Sciences Limited (CFSL) completed a block acquisition of a majority stake in Vinpai, buying 78.68% of the share capital (rising to 83.82% after conversion of convertible bonds) at EUR 3.60 per share. CFSL plans a simplified cash tender offer for remaining shares and may seek a squeeze-out to delist Vinpai from Euronext Growth Paris.
- Buyers
- Camlin Fine Sciences Limited
- Targets
- Vinpai
- Sellers
- Significant shareholders (unnamed)
- Industry
- Food & Beverage
- Location
- Brittany, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd
December 14, 2021
Pharmaceuticals
CSL Limited has launched an all-cash tender offer to acquire all publicly held shares of Vifor Pharma Ltd for US$179.25 per share, implying an aggregate equity value of approximately US$11.7 billion. The transaction, unanimously recommended by both boards, expands CSL's presence in nephrology, iron deficiency and cardio-renal therapies and will be funded through a combination of equity placement, new debt and existing cash facilities.
-
PAI Partners Agrees to Acquire Majority Stake in ECF Group
June 14, 2023
Logistics & Distribution
PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.
-
Bain Capital and Cinven to Acquire Lonza Specialty Ingredients
February 8, 2021
Manufacturing
Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.
-
Vance Street Capital Acquires Excel Scientific
January 12, 2021
Medical Devices
Los Angeles-based private equity firm Vance Street Capital acquired Excel Scientific, a Victorville, California manufacturer of microplate sealing films and foils used by life science, biotech, pharmaceutical and diagnostic laboratories. Founder Bambi Lyn Cahilly retains an ownership stake; terms were not disclosed and Vance Street plans to invest in growth and product innovation across life-science end markets.
-
PAI Partners Acquires Majority Stake in Nutripure
July 25, 2024
Consumer Products
PAI Partners, through its PAI Mid-Market Fund, has agreed to acquire a majority, controlling stake in Nutripure from Ardian. The investment will support Nutripure’s product development, community growth and European expansion while founders and Bpifrance remain shareholders.
-
Valent BioSciences Acquires FBSciences
January 30, 2023
Agriculture
Valent BioSciences LLC, a subsidiary of Sumitomo Chemical Co., Ltd., has acquired FBSciences Holdings, Inc., a Collierville, Tennessee–headquartered developer of naturally derived biostimulants, biopesticides, and crop nutrition solutions. The acquisition strengthens Valent's capabilities and market position in the rapidly growing global biostimulant and biorationals market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.